Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gordon Smith

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
Neurology|April 26, 2020
Attracting neurology's next generation: A qualitative study of specialty choice and perceptionsJustin T Jordan, Carolyn Cahill, Tasha Ostendorf, et al.
Journal of the Peripheral Nervous System : JPNS|November 21, 2023
Plasma proteomic analysis on neuropathic pain in idiopathic peripheral neuropathy patientsPerry T C van Doormaal, Simone Thomas, Senda Ajroud-Driss, et al.
Muscle & Nerve|December 28, 2017
3,4-diaminopyridine base effectively treats the weakness of Lambert-Eaton myastheniaDonald B Sanders, Vern C Juel, Yadollah Harati, et al.
Neurology|July 20, 2019
Clinician-rated measures for distal symmetrical axonal polyneuropathy: ACTTION systematic reviewJennifer S Gewandter, Christopher H Gibbons, Marta Campagnolo, et al.
JAMA Neurology|October 23, 2023
Safety and Efficacy of Topiramate in Individuals With Cryptogenic Sensory Peripheral Neuropathy With Metabolic Syndrome: The TopCSPN Randomized Clinical TrialA Gordon Smith, J Robinson Singleton, Adrienne Aperghis, et al.
Muscle & Nerve|July 23, 2016
Content validity of symptom-based measures for diabetic, chemotherapy, and HIV peripheral neuropathyJennifer S Gewandter, Laurie Burke, Guido Cavaletti, et al.
Muscle & Nerve|July 27, 2010
Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs. NPhys trialPeter J Dyck, Carol J Overland, Phillip A Low, et al.
Neurology|July 29, 2018
Trial designs for chemotherapy-induced peripheral neuropathy prevention: ACTTION recommendationsJennifer S Gewandter, Joanna Brell, Guido Cavaletti, et al.
Archives of Neurology|September 19, 2012
"Unequivocally Abnormal" vs "Usual" Signs and Symptoms for Proficient Diagnosis of Diabetic Polyneuropathy: Cl vs N Phys TrialPeter J Dyck, Carol J Overland, Phillip A Low, et al.
Neurology|May 6, 2018
Validation of a simple disease-specific, quality-of-life measure for diabetic polyneuropathy: CAPPRIKelly G Gwathmey, Reza Sadjadi, William B Horton, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Neurology|April 26, 2020
Attracting neurology's next generation: A qualitative study of specialty choice and perceptionsJustin T Jordan, Carolyn Cahill, Tasha Ostendorf, et al.
Journal of the Peripheral Nervous System : JPNS|November 21, 2023
Plasma proteomic analysis on neuropathic pain in idiopathic peripheral neuropathy patientsPerry T C van Doormaal, Simone Thomas, Senda Ajroud-Driss, et al.
Muscle & Nerve|December 28, 2017
3,4-diaminopyridine base effectively treats the weakness of Lambert-Eaton myastheniaDonald B Sanders, Vern C Juel, Yadollah Harati, et al.
Neurology|July 20, 2019
Clinician-rated measures for distal symmetrical axonal polyneuropathy: ACTTION systematic reviewJennifer S Gewandter, Christopher H Gibbons, Marta Campagnolo, et al.
JAMA Neurology|October 23, 2023
Safety and Efficacy of Topiramate in Individuals With Cryptogenic Sensory Peripheral Neuropathy With Metabolic Syndrome: The TopCSPN Randomized Clinical TrialA Gordon Smith, J Robinson Singleton, Adrienne Aperghis, et al.
Muscle & Nerve|July 23, 2016
Content validity of symptom-based measures for diabetic, chemotherapy, and HIV peripheral neuropathyJennifer S Gewandter, Laurie Burke, Guido Cavaletti, et al.
Muscle & Nerve|July 27, 2010
Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs. NPhys trialPeter J Dyck, Carol J Overland, Phillip A Low, et al.
Neurology|July 29, 2018
Trial designs for chemotherapy-induced peripheral neuropathy prevention: ACTTION recommendationsJennifer S Gewandter, Joanna Brell, Guido Cavaletti, et al.
Archives of Neurology|September 19, 2012
"Unequivocally Abnormal" vs "Usual" Signs and Symptoms for Proficient Diagnosis of Diabetic Polyneuropathy: Cl vs N Phys TrialPeter J Dyck, Carol J Overland, Phillip A Low, et al.
Neurology|May 6, 2018
Validation of a simple disease-specific, quality-of-life measure for diabetic polyneuropathy: CAPPRIKelly G Gwathmey, Reza Sadjadi, William B Horton, et al.
Pageof 10